loading
전일 마감가:
$135.62
열려 있는:
$135.56
하루 거래량:
2.70M
Relative Volume:
0.40
시가총액:
$232.09B
수익:
$42.34B
순이익/손실:
$13.50B
주가수익비율:
17.32
EPS:
7.71
순현금흐름:
$6.66B
1주 성능:
+0.04%
1개월 성능:
-0.99%
6개월 성능:
+18.50%
1년 성능:
+28.72%
1일 변동 폭
Value
$133.31
$136.41
1주일 범위
Value
$132.93
$137.06
52주 변동 폭
Value
$99.71
$140.84

애보트 래버러토리스 Stock (ABT) Company Profile

Name
명칭
Abbott Laboratories
Name
전화
(224) 667-6100
Name
주소
100 ABBOTT PARK ROAD, ABBOTT PARK, IL
Name
직원
114,000
Name
트위터
@AbbottNews
Name
다음 수익 날짜
2025-04-16
Name
최신 SEC 제출 서류
Name
ABT's Discussions on Twitter

ABT을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Medical Devices icon
ABT
Abbott Laboratories
133.50 232.09B 42.34B 13.50B 6.66B 7.71
Medical Devices icon
BSX
Boston Scientific Corp
101.44 148.00B 17.55B 2.03B 2.72B 1.37
Medical Devices icon
SYK
Stryker Corp
376.49 146.09B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
87.68 112.11B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
74.58 44.79B 5.54B 4.18B 623.10M 7.00

애보트 래버러토리스 Stock (ABT) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2024-10-08 개시 Oppenheimer Outperform
2024-09-19 개시 Piper Sandler Overweight
2024-07-30 다운그레이드 Edward Jones Buy → Hold
2024-05-30 개시 Goldman Buy
2023-07-21 업그레이드 Wolfe Research Underperform → Peer Perform
2023-05-30 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2023-04-20 재확인 Barclays Overweight
2023-04-20 재확인 Bernstein Outperform
2023-04-20 재확인 JP Morgan Overweight
2023-04-20 재확인 Raymond James Outperform
2023-04-20 재확인 UBS Buy
2023-04-20 재확인 Wolfe Research Underperform
2023-03-29 개시 UBS Buy
2022-10-26 개시 Mizuho Neutral
2022-10-18 개시 Barclays Overweight
2022-10-12 개시 Jefferies Hold
2022-07-06 개시 Wolfe Research Underperform
2022-03-02 재개 BofA Securities Buy
2022-01-27 재확인 Credit Suisse Outperform
2022-01-27 재확인 Morgan Stanley Overweight
2022-01-27 재확인 Raymond James Outperform
2022-01-27 재확인 UBS Buy
2021-12-10 개시 RBC Capital Mkts Outperform
2021-10-27 업그레이드 Atlantic Equities Neutral → Overweight
2021-10-14 개시 Redburn Neutral
2021-05-25 개시 Barclays Overweight
2021-04-15 개시 Atlantic Equities Neutral
2021-01-28 업그레이드 BTIG Research Neutral → Buy
2020-09-11 개시 Wolfe Research Outperform
2020-06-01 다운그레이드 Goldman Neutral → Sell
2020-03-05 개시 Citigroup Buy
2020-02-13 개시 Goldman Neutral
2020-02-06 재개 BTIG Research Neutral
2020-01-02 다운그레이드 Guggenheim Buy → Neutral
2019-06-13 재확인 BofA/Merrill Buy
2019-02-07 재확인 BofA/Merrill Buy
2019-01-02 다운그레이드 Citigroup Neutral → Sell
2018-11-30 업그레이드 Goldman Neutral → Buy
2018-10-16 개시 Barclays Overweight
2018-06-27 개시 Bernstein Outperform
2018-01-30 재확인 Citigroup Neutral
2018-01-25 재확인 Stifel Buy
2018-01-25 업그레이드 William Blair Mkt Perform → Outperform
2018-01-03 개시 Evercore ISI Outperform
2018-01-02 업그레이드 JP Morgan Neutral → Overweight
2018-01-02 업그레이드 Morgan Stanley Equal-Weight → Overweight
2017-10-19 재확인 RBC Capital Mkts Outperform
2017-10-19 재확인 Stifel Buy
모두보기

애보트 래버러토리스 주식(ABT)의 최신 뉴스

pulisher
01:11 AM

Abbott Wins Dismissal of Whistleblower’s Medicare Fraud Suit - Bloomberg Law News

01:11 AM
pulisher
09:17 AM

Abbott Declares 406th Consecutive Quarterly Dividend - marketscreener.com

09:17 AM
pulisher
09:03 AM

Abbott Laboratories' Whole Blood Concussion Test Approved by Health Canada - marketscreener.com

09:03 AM
pulisher
08:00 AM

Abbott Receives Health Canada Authorization for Whole Blood Rapid Test to Help Assess Suspected Concussions - PR Newswire Canada

08:00 AM
pulisher
05:20 AM

Blood Screening Market Outlook | Key Players: Abbott Laboratories, Roche, Grifols, BioMérieux - openPR.com

05:20 AM
pulisher
03:44 AM

Deep Venous Disease Treatment Market Key Players Analysis - openPR.com

03:44 AM
pulisher
12:47 PM

1 Unpopular Stock that Should Get More Attention and 2 to Avoid - FinancialContent

12:47 PM
pulisher
Jun 15, 2025

Jim Cramer Calls Abbott “Really Excellent” - Insider Monkey

Jun 15, 2025
pulisher
Jun 14, 2025

Electrophysiology Devices Market Share Leaders: Abbott, Acutus Medical, and Biosense Webster - openPR.com

Jun 14, 2025
pulisher
Jun 13, 2025

Abbott Laboratories (ABT) Maintains Quarterly Dividend of $0.59 - GuruFocus

Jun 13, 2025
pulisher
Jun 13, 2025

Abbott Declares 406Th Consecutive Quarterly Dividend, Payable on August 15, 2025 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Piper Sandler names Abbott, Edwards, Glaukos as top medtech catalyst picks - Investing.com Nigeria

Jun 13, 2025
pulisher
Jun 13, 2025

Abbott Laboratories Keeps Quarterly Dividend at $0.59 per Share, Payable August 15 to Shareholders as of July 15 - marketscreener.com

Jun 13, 2025
pulisher
Jun 13, 2025

Clinical Immunochemistry Analyzers Market projected reach USD 6.9 billion by 2034, growing at a CAGR of 4.4% | Exactitude Consultancy - GlobeNewswire Inc.

Jun 13, 2025
pulisher
Jun 12, 2025

Abbott Laboratories Stock Sees RS Rating Rise To 82 - Investor's Business Daily

Jun 12, 2025
pulisher
Jun 12, 2025

Stocks To Watch: Abbott Laboratories Sees RS Rating Rise To 82 - MSN

Jun 12, 2025
pulisher
Jun 12, 2025

Abbott and Medtronic best positioned manufacturers in US neurology market - PharmaLive

Jun 12, 2025
pulisher
Jun 11, 2025

Abbott Laboratories (NYSE:ABT) Partners With Tandem To Develop Dual Sensor Diabetes Solutions - simplywall.st

Jun 11, 2025
pulisher
Jun 10, 2025

Tandem, Abbott team on insulin delivery with glucose-ketone sensor - MedTech Dive

Jun 10, 2025
pulisher
Jun 10, 2025

Tandem Diabetes (TNDM) Partners with Abbott for Innovative Diabe - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

Tandem, Abbott in deal to combine insulin delivery with glucose-ketone sensor - Seeking Alpha

Jun 10, 2025
pulisher
Jun 10, 2025

Abbott (ABT) Partners with Tandem Diabetes for Advanced Diabetes Management Solutions | ABT Stock News - GuruFocus

Jun 10, 2025
pulisher
Jun 10, 2025

3 Low-Volatility Stocks in Hot Water - FinancialContent

Jun 10, 2025
pulisher
Jun 09, 2025

Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector? - MSN

Jun 09, 2025
pulisher
Jun 06, 2025

Abbott Laboratories (ABT) Stock Dips Slightly on NYSE, Long-Term Gains Remain Solid - Daily Chhattisgarh News

Jun 06, 2025
pulisher
Jun 05, 2025

Is Abbott (ABT) a Buy as Wall Street Analysts Look Optimistic? - Yahoo Finance

Jun 05, 2025
pulisher
Jun 04, 2025

Thousands of lawsuits over baby formula should stay where filed, court says - Reuters

Jun 04, 2025
pulisher
Jun 04, 2025

Abbott (ABT) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance

Jun 04, 2025
pulisher
Jun 04, 2025

Abbott Laboratories (ABT) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Jun 04, 2025
pulisher
Jun 02, 2025

Test Strip Market Is Booming So Rapidly 2025-2032 -Abbott - openPR.com

Jun 02, 2025
pulisher
Jun 02, 2025

Abbott Announces FDA Approval Of Tendyne Transcatheter Mitral Valve Replacement System - insights.citeline.com

Jun 02, 2025
pulisher
Jun 02, 2025

Abbott Laboratories Stock: Is ABT Outperforming The Health Care Sector? - Barchart.com

Jun 02, 2025
pulisher
Jun 02, 2025

Goldman Sachs Adjusts Price Target on Abbott Laboratories to $153 From $147, Maintains Buy Rating - marketscreener.com

Jun 02, 2025
pulisher
Jun 01, 2025

There's Been No Shortage Of Growth Recently For Abbott Laboratories' (NYSE:ABT) Returns On Capital - Yahoo Finance

Jun 01, 2025
pulisher
May 30, 2025

Abbott Tendyne TMVR secures FDA clearance - BioWorld MedTech

May 30, 2025
pulisher
May 30, 2025

Cardiac Marker Analyzer Market Is Booming WorldwideAbbott, Roche Diagnostics - openPR.com

May 30, 2025
pulisher
May 30, 2025

Abbott Labs (ABT) Stock Ticks Lower: Gauging the Pulse and Future Price Points - Daily Chhattisgarh News

May 30, 2025
pulisher
May 30, 2025

Abbott Benefits From Libre & Biosimilars Amid FX, Cost Headwinds - TradingView

May 30, 2025
pulisher
May 30, 2025

Cancer Cell Market Projected to Witness Massive GrowthAbbott Laboratories, Novartis - openPR.com

May 30, 2025
pulisher
May 30, 2025

Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT) and Pfizer (PFE) - The Globe and Mail

May 30, 2025
pulisher
May 29, 2025

Abbott (ABT) Rises Higher Than Market: Key Facts - Yahoo Finance

May 29, 2025
pulisher
May 29, 2025

Syphilis Market Growth Projections 2023-2032: DelveInsight - openPR.com

May 29, 2025
pulisher
May 29, 2025

MotoAmerica Adopts Ground-Breaking Global Standard for Concussion Safety with Abbott's i-STAT TBI Blood Test - Sports Illustrated

May 29, 2025
pulisher
May 29, 2025

Abbott reports positive dual-chamber pacemaker results - MassDevice

May 29, 2025
pulisher
May 28, 2025

An Abbott competitor drops out — plus, a special circumstance for Nvidia earnings - CNBC

May 28, 2025
pulisher
May 28, 2025

Abbott Laboratories (NYSE:ABT) Gains FDA Nod For Tendyne Mitral Valve System - simplywall.st

May 28, 2025
pulisher
May 28, 2025

Abbott (ABT) Gains Marginal Benefit from Boston Scientific's Str - GuruFocus

May 28, 2025
pulisher
May 28, 2025

Cancer Diagnostics Market Is Booming WorldwideRoche, Abbott Laboratories - openPR.com

May 28, 2025
pulisher
May 28, 2025

Abbott Stock Gains Following FDA Approval of the Tendyne System - Yahoo

May 28, 2025

애보트 래버러토리스 (ABT) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
medical_devices BSX
$101.46
price up icon 1.72%
medical_devices SYK
$376.49
price down icon 0.22%
medical_devices MDT
$87.58
price up icon 0.43%
medical_devices EW
$74.59
price down icon 0.71%
$83.34
price up icon 1.74%
자본화:     |  볼륨(24시간):